Drug giant Pfizer Inc. said that it plans to pare an unspecified number of jobs at its Cambridge research center, opened last June, as part a broader cutback across its research operations.
Pfizer recently struck a cancer immunotherapy alliance with Rockland-based EMD Serono, a US division of Germany’s Merck Serono.
Pfizer last summer consolidated several Boston area sites into its new research center outside Kendall Square, which employed about 1,000 researchers and scientists. The company wouldn’t say how many of those employees will be affected by the cuts.
Comentarios recientes